Henry Horhey

PHD Doctor of Philosophy,  CharitĂ© - Universitätsmedizin Berlin 

Location: India

Consulting Services

Sales and Marketing Admin and Customer Support

Areas Of Interest

Accident Structure, Molecular Subvalvular Stenosis, Aortic DNA, Immobilized Apert Crouzon Disease Plant, Dracunculus Microanalyses, Electron Probe Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels Biomedical Ontology Academic Dissertation Testes, Undescended FTA-ABS Tests B Lymphocyte Light Chain Gene Rearrangement Vendor Clathrin-Associated Proteins Megalocytiviruses Dysphasia, Sensory Daisy, Oxeye Tongue Worms Escherichia coli Vaccine Budesonide Formoterol Fumarate Drug Combination Planning, Advance Medical Transcript, RNA Primary Chloraminophene Monomethylglycine Dehydrogenase Deuteromycotas Papillary Cystadenoma Myeloid Leukemia, Chronic, Stable-Phase Non-Clinical Distribution Ephedrine Sulfate

Professional Narrative

Dr. Henry Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 1993
Director Medicine, Harvard Med 2009

Education

Master of Science in physician assistant, Perelman School of Medicine 2019
Director Medicine, Harvard Medical School 2018

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :